Ultrasound-Guided Access for Peripheral Venous Catheterization

(TVA-2026 Trial)

Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Truway Health, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

TruVascular Access - TVA-2026 is a prospective, randomized clinical study evaluating whether ultrasound-guided peripheral vascular access improves first-attempt cannulation success compared with conventional landmark, visualization, and palpation-guided techniques in adults who require clinically indicated peripheral venous access.

Participants will be assigned to either an ultrasound-guided vascular-access workflow or a standard vascular-access workflow. The primary outcome is successful placement of a functional peripheral vascular catheter on the first cannulation attempt. Secondary outcomes include the total number of cannulation attempts, time to successful vascular access, successful access within two attempts, need for rescue or escalation to another vascular-access method, patient-reported procedural pain, access-related complications, catheter function, and operator-reported procedural difficulty.

The study will also collect information about participant characteristics, difficult intravenous access features, vascular anatomy, catheter characteristics, operator experience, and other procedural factors that may influence successful vascular access. These data may be used to identify patient and procedural characteristics associated with first-attempt success and to improve future vascular-access workflows.

Participant safety will take priority over study assignment. If the assigned technique is unsuccessful or clinically inappropriate, the treating clinician may use an alternative or rescue vascular-access method according to applicable clinical practice and study procedures.

Who Is on the Research Team?

GC

Gavin C Solomon, M.D.

Principal Investigator

Truway Health, Inc.

Are You a Good Fit for This Trial?

This trial is for adults who need a peripheral IV line placed as part of their medical care. People with conditions making it unsafe or inappropriate to participate, as judged by the clinical team, will not be included.

Inclusion Criteria

I am 18 or older and able to give my consent to join the study.
I am able to have a standard or ultrasound-guided vascular access procedure.
Requires peripheral venous vascular access as part of clinically indicated care
See 6 more

Exclusion Criteria

Immediate life-threatening or emergency circumstances in which study enrollment, consent, assent, parental permission, or randomization could delay medically necessary treatment
Existing functional vascular access that eliminates the clinical need for a new peripheral intravenous catheter
I am under 18 and do not have parental permission or assent, unless allowed by exception.
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • Standard Peripheral Vascular Access
  • Ultrasound-Guided Peripheral Vascular Access

Trial Overview

The study compares two ways of placing an IV: one uses ultrasound guidance and the other uses standard methods like feeling for veins or looking at them. Participants are randomly assigned to either group to see which method works better on the first try.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Ultrasound-Guided Peripheral Vascular AccessExperimental Treatment2 Interventions
Group II: Standard Peripheral Vascular AccessActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Truway Health, Inc.

Lead Sponsor